Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and manufacturing facilities and a global ...

About Piramal Pharma Limited: Piramal Pharma Limited (PPL, NSE: PPLPHARMA I BSE: 543635), offers a portfolio of differentiated products and services through its 17* global development and ...

Pakistan Petroleum Limited (PSX: PPL), a key player in the country’s energy sector, reported its financial and operational performance for the first half of the fiscal year 2025 (1HFY25 ...

The campaign features their brand ambassador Jisshu Sengupta. Mumbai: Piramal Pharma Ltd’s consumer products division (CPD) announced the launch of its new digital campaign for 'Polycrol,' its ...

The Lehigh Valley’s tallest, most recognizable building has a buyer. PPL Corp. said Friday in a news release it has an agreement to sell the 24-story PPL Building to Scranton-based developer D&D ...

IF YOU’D LIKE TO READ THE ENTIRE LETTER, YOU CAN FIND IT BOTH ON MY FACEBOOK PAGE AND ON WGAL DOT COM RIGHT NOW AND BRIAN ROCH News 8 On Your Side continues to hear from PPL customers about ...

Pharma major Hetero has unveiled its new corporate logo, brand architecture, visual and verbal identity of the company. “With a people-first approach, this distinctive identity will guide and ...

PPL (PPL) closed at $28.97 in the latest trading session, marking a +0.49% move from the prior day. This move lagged the S&P 500's daily gain of 1.12%. Elsewhere, the Dow gained 1.01%, while the ...

In the latest trading session, PPL (PPL) closed at $29.13, marking a -0.88% move from the previous day. This change lagged the S&P 500's daily gain of 0.43%. Meanwhile, the Dow gained 0.25% ...

www.piramalpharmasolutions.com | Twitter | LinkedIn About Piramal Pharma Ltd. Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through end-to-end ...

Yesterday, the court heard that Holmes did it once more, sending reports that prominently featured the logo of Schering-Plough, the large pharmaceutical company that was acquired by Merck in 2009.